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Patient recruitment is a major challenge for randomised
trials. Reviews of publicly funded UK trials have found
that 45 to 69% fail to recruit to target. This increases
costs, delays results, and adversely impacts on the feasi-
bility of conducting trials for conditions where there is a
limited patient pool.
For some conditions a patient requires treatment on
multiple occasions. For example, patients with sickle cell
disease require pain relief for each pain crisis, or women
having fertility treatment undergo multiple treatment
cycles until becoming pregnant. The current norm is for
patients to be included for only one treatment episode.
We propose a re-randomisation design, allowing
patients to be randomised on multiple occasions, which
could substantially increase the recruitment rate.
We describe some properties of the re-randomisation
design, such as the conditions required to obtain unbiased
estimates of the treatment effect and control type I error
rates, and offer advice on practical design and analysis
issues. We show that this design can reduce the required
number of patients compared with a parallel group design.
It can be used in a wider variety of settings than a cross-
over design and may be more patient-centred as the num-
ber of treatment periods is determined by participants
rather than the trial design. We also highlight situations
where this design would be inappropriate.
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